← GYRE THERAPEUTICS, INC.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Net Income (Loss) Available to Common Stockholders, Basic | — | ($25.5m) |
($30.1m)
-17.81%
|
($55.2m)
-83.59%
|
($56.2m)
-1.93%
|
— | — | ($92.9m) |
$12.1m
+113.00%
|
$5.0m
-58.40%
|
— | |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | ($16.9m) | ($21.6m) | ($30.1m) | ($55.2m) | ($56.2m) | ($87.9m) | ($8.2m) | ($85.5m) | $17.9m | $9.9m | — | |
| Net Income (Loss) Attributable to Noncontrolling Interest | — | — | — | — | — | — | — | $7.5m | $5.8m | $4.9m | — | |
| Depreciation, Depletion and Amortization | $389k | $173k | $149k | $146k | $138k | $290k | $230k | $1.1m | $1.5m | $2.5m | $3.1m | |
| Depreciation | $400k | $200k | $100k | $146k | $138k | $290k | $230k | $1.0m | $1.3m | $2.0m | $3.1m | |
| Amortization of Debt Issuance Costs | — | — | — | — | — | — | — | — | $9k | — | — | |
| Amortization of Intangible Assets | — | — | — | — | — | — | — | $100k | $38k | $576k | — | |
| Amortization of land use rights | — | — | — | — | — | — | $42k | $40k | $39k | $39k | — | |
| Deferred Income Tax Expense (Benefit) | — | — | — | — | — | — | — | ($834k) | ($1.0m) | ($1.1m) | ($2.8m) | |
| Deferred income taxes, net | — | — | — | — | — | — | ($838k) | ($1.2m) | ($1.0m) | ($1.1m) | ($2.8m) | |
| Share-based Payment Arrangement, Noncash Expense | $635k | $863k | $2.6m | $3.2m | $3.6m | $3.4m | $1.3m | $7.3m | $831k | $7.2m | $9.9m | |
| Share-based Payment Arrangement, Expense | $635k | $863k | $2.6m | $3.2m | $3.6m | $3.4m | $1.3m | $7.3m | $831k | $7.2m | $9.9m | |
| Stock-based compensation | $635k | $863k | $2.6m | $3.2m | $3.6m | $3.4m | $1.3m | $7.3m | $831k | $7.2m | $9.9m | |
| Equity Method Investment, Other than Temporary Impairment | — | — | — | — | — | — | ($1.3m) | ($1.0m) | $0 | $0 | — | |
| Other Nonoperating Income (Expense) | $86k | $261k | $1.6m | ($39k) | $659k | ($87k) | — | — | ($1.7m) | ($1.5m) | — | |
| Purchase of equity method investment | — | — | — | — | — | — | ($1.3m) | ($1.0m) | ($1.7m) | — | — | |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts Receivable | ($461k) | ($7k) | — | $15.0m | ($11.7m) | ($1.5m) | — | — | $5.3m | $10.8m | ($1.4m) | |
| Change in fair value of receivables from GCBP | — | — | — | — | — | — | — | ($39k) | $239k | ($39k) | — | |
| Accounts receivable | $461k | $7k | — | ($15.0m) | $11.7m | $1.5m | — | $285k | ($5.3m) | ($10.8m) | ($1.4m) | |
| Increase (Decrease) in Inventories | — | — | — | — | — | — | — | ($1.7m) | $2.1m | $3.6m | ($2.1m) | |
| Inventories | — | — | — | — | — | — | ($879k) | $1.7m | ($2.1m) | ($3.6m) | ($2.1m) | |
| Increase (Decrease) in Accounts Payable | ($102k) | ($90k) | $500k | $3.0m | $1.7m | $500k | ($6.2m) | $192k | ($245k) | $13k | ($551k) | |
| Accrued interest on bank deposit | — | — | — | — | — | — | — | ($633k) | ($1.0m) | $28k | — | |
| Accrued expenses and other liabilities | — | — | — | — | — | — | $1.9m | $1.4m | ($1.5m) | $946k | — | |
| Prepaid and other assets | $956k | ($351k) | ($2.9m) | ($490k) | ($3.0m) | $3.9m | $1.6m | ($82k) | $520k | ($206k) | — | |
| Net Cash Provided by (Used in) Operating Activities | ($18.5m) |
($19.9m)
-7.95%
|
($28.6m)
-43.19%
|
($43.6m)
-52.74%
|
($55.0m)
-26.22%
|
($83.8m)
-52.15%
|
($33.1m)
+60.48%
|
$25.9m
+178.23%
|
($3.6m)
-114.06%
|
$1.0m
+127.74%
|
($4.9m)
-588.61%
|
|
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Property, Plant, and Equipment | $468k | $23k | $376k | $64k | ($267k) | ($839k) | $727k | $8.5m | $2.3m | $1.2m | ($2.2m) | |
| Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property | $600k | $0 | ($116k) | — | — | — | $498k | $628k | $66k | $4k | ($319k) | |
| Gain (Loss) on Disposition of Property Plant Equipment | $557k | $0 | ($116k) | — | — | — | $498k | ($628k) | ($66k) | ($4k) | ($319k) | |
| Proceeds from sale of equipment | $1.7m | — | — | — | — | — | — | $664k | $401k | $30k | — | |
| Cash, Cash Equivalents, and Short-term Investments | $17.1m | $32.4m | $120.1m | $76.9m | $81.9m | $46.9m | $21.7m | $33.5m | — | — | — | |
| Debt Securities, Available-for-sale, Realized Gain (Loss) | — | — | — | — | — | — | $0 | — | — | — | — | |
| Payments to Acquire Investments | $13.4m | $25.5m | — | — | $267k | $839k | — | — | — | — | ($1.5m) | |
| Net Cash Provided by (Used in) Investing Activities | — | ($11.2m) | ($71.3m) | $27.4m | $9.7m | $48.2m | $55.4m | ($19.8m) | ($19.9m) | ($474k) | $2.9m | |
| Cash flows from financing activities: | ||||||||||||
| Gain (Loss) on Extinguishment of Debt | $99k | $0 | — | — | — | — | — | — | — | — | — | |
| Bad debt expense and other non-cash items | — | — | — | — | — | — | $22k | ($61k) | $170k | ($63k) | — | |
| Proceeds from Issuance of Common Stock | $958k | $5.3m | — | — | — | — | — | — | $773k | $23.5m | $0 | |
| Proceeds from the issuance of common stock | $958k | $5.3m | $106.8m | — | — | — | — | — | $773k | $23.5m | — | |
| Dividends paid | — | — | — | — | — | — | $45 | — | — | — | — | |
| Dividends Payable, Current | — | — | — | — | — | — | $8 | — | — | — | — | |
| Net Cash Provided by (Used in) Financing Activities | — | $21.1m |
$111.3m
+428.09%
|
$327k
-99.71%
|
$60.4m
+18363.61%
|
$49.6m
-17.93%
|
($45.0m)
-190.83%
|
$2.5m
+105.55%
|
$2.1m
-15.92%
|
$24.4m
+1059.75%
|
$2.8m
-88.51%
|
|
| Net increase (decrease) in cash and cash equivalents | ($18.8m) | $4.2m | $11.5m | ($15.9m) | $15.0m | $14.0m | ($22.7m) | $8.3m | ($21.7m) | $25.3m | — | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | — | $11.5m | ($15.9m) | $15.0m | $14.0m | ($22.7m) | $8.3m | ($21.7m) | $25.3m | $57.1m | |
| Cash and cash equivalents at beginning of the period | — | $19.8m | $31.3m | $15.4m | $30.4m | $44.3m | $21.7m | $33.5m | $11.8m | $37.1m | — | |
| Effect of exchange rate changes on cash and cash equivalents | — | — | — | — | — | — | ($1.9m) | ($298k) | ($273k) | $343k | $1.3m | |
| Additional Supplementary Disclosures | ||||||||||||
| Additional Supplementary Disclosures | ||||||||||||
| Proceeds from Stock Options Exercised | — | — | — | — | — | — | — | $0 | $1.9m | $2.4m | — | |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Income Taxes Paid, Net | — | — | — | — | — | — | $6.3m | $6.3m | $8.5m | $5.6m | — | |
| Additional Financial Items | ||||||||||||
| Derivative, Gain (Loss) on Derivative, Net | $1.1m | — | — | — | — | — | — | — | — | — | — | |
| Gain (Loss) on Disposition of Assets | $1.7m | ($18k) | — | — | — | — | $57.2m | — | — | ($4k) | — | |
| Gain (Loss) on Disposition of Business | — | — | — | — | — | — | — | ($2.7m) | — | — | — | |
| General and Administrative Expense | $9.3m | $10.0m | $12.4m | $13.4m | $16.2m | $19.0m | $17.4m | $14.7m | $16.1m | $20.8m | — | |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | — | — | — | — | — | — | — | ($85.5m) | $17.9m | $9.9m | — | |
| Income Tax Expense (Benefit) | — | — | — | — | — | — | $348k | $8.5m | $5.3m | $4.6m | — | |
| Operating Expenses | $20.8m | $22.8m | $33.8m | $57.3m | $78.3m | $95.2m | $9.4m | $176.0m | $85.7m | $105.1m | — | |
| Operating Lease, Expense | — | — | — | $600k | $700k | $1.7m | $1.7m | $500k | $700k | $900k | — | |
| Payments of Financing Costs | — | — | — | — | — | — | — | — | — | $1.5m | — | |
| Revenue from Contract with Customer, Including Assessed Tax | — | — | — | — | — | — | — | $113.5m | $105.8m | — | — | |
| Noncash lease expense | — | — | — | — | — | — | $404k | $355k | $672k | $777k | — | |
| Change in fair value of derivative liabilities | — | — | — | — | — | — | — | $39k | $239k | $39k | — | |
| Change in fair value of warrant liability | — | — | — | — | — | — | — | $9.3m | ($7.2m) | ($2.7m) | — | |
| Equity loss of unconsolidated affiliates | — | — | — | — | — | — | $251k | $1.3m | $37k | $77k | — | |
| Notes receivable | — | — | — | — | — | — | — | $1.1m | ($4.0m) | ($1.1m) | — | |
| Income tax payable | — | — | — | — | — | — | ($1.3m) | $3.0m | ($2.2m) | $44k | — | |
| Other noncurrent liabilities | — | — | — | — | — | — | — | ($102k) | $23k | ($47k) | — | |
| Due to related parties | — | — | — | — | — | — | — | $425k | ($83k) | ($1k) | — | |
| Operating lease liabilities | — | — | — | — | — | — | ($429k) | ($473k) | ($816k) | ($744k) | — | |
| Acquisition of intangible assets | — | — | — | — | — | — | ($13k) | ($69k) | ($813k) | ($733k) | — | |
| Purchase of certificates of deposit | — | — | — | — | — | — | ($7.5m) | ($15.7m) | ($15.5m) | ($14.0m) | — | |
| Offering costs paid | — | — | — | — | — | — | — | — | ($536k) | ($1.5m) | — | |
| Proceeds from the exercise of stock options | — | — | — | — | — | — | — | $0 | $1.9m | $2.4m | — | |
| Right-of-use asset obtained in exchange for operating lease liabilities | — | — | — | — | — | — | $57k | $277k | $2.0m | $63k | — |